Effect of oral contraceptives on risk of cervical cancer in women with human papillomavirus infection: The IARC multicentric case-control study

Lancet

Volumn 359, Issue 9312, 2002, Pages 1085-1092

  Moreno, Victor ^a   Bosch, F Xavier ^a   Muñoz, Nubia ^b   Meijer, Chris J L M ^c   Shah, Keerti V ^d   Walboomers, Jan M M ^c   Herrero, Rolando ^e   Franceschi, Silvia ^b  

^a HOSPITAL DURAN I REYNALS   (Spain)

^b INTERNATIONAL AGENCY FOR RESEARCH ON CANCER   (France)

^c VU UNIVERSITY MEDICAL CENTER   (Netherlands)

^d JOHNS HOPKINS UNIVERSITY   (United States)

^e Hospital Mexico Costa Rica   (Costa Rica)

Author keywords

[No Author keywords available]

Indexed keywords

ORAL CONTRACEPTIVE AGENT; VIRUS DNA;

ARTICLE; CANCER INVASION; CANCER RISK; CANCER SCREENING; CARCINOMA IN SITU; CONTROLLED STUDY; DNA DETERMINATION; FEMALE; HUMAN; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; RISK ASSESSMENT; UTERINE CERVIX CARCINOMA; VIRUS INFECTION; WART VIRUS;

EID: 0037197047     PISSN: 01406736     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0140-6736(02)08150-3     Document Type: Article

References (30)

1. Oral contraceptives and cancer of the cervix uteri: A meta-analysis
2. The causal link between human papillomavirus and invasive cervical cancer: A population-based case-control study in Colombia and Spain
3. Human papillomavirus is a necessary cause of invasive cervical cancer worldwide
4. Oral contraceptive use, human papillomavirus infection, and risk of early cytological abnormalities of the cervix
5. Oral contraceptives as risk factors for cervical adenocarcinomas and squamous cell carcinomas
6. Different risk factor patterns for high-grade and low-grade intraepithelial lesions on the cervix among HPV-positive and HPV-negative young women
7. Sexual behaviour and smoking as determinants of cervical HPV infection and of CIN3 among those infected: A case-control study nested within the Manchester cohort
8. Risk factors for cervical cancer in Thailand: A case-control study
9. Causes of cervical cancer in the Philippines: A case-control study
10. The viral origin of cervical cancer in Rabat, Morocco
11. Human papillomavirus and invasive cervical cancer in Brazil
12. HPV types and cofactors causing cervical cancer in Peru
13. Human papillomavirus infection and invasive cervical cancer in Paraguay
14. Risk factors for cervical cancer in Colombia and Spain
15. Human papillomavirus and cervical intraepithelial neoplasia grade III/carcinoma in situ: A case-control study in Spain and Colombia
16. Risk factors for cervical intraepithelial neoplasia grade III/carcinoma in situ in Spain and Colombia
17. Risk factors for progression of cervical intraepithelial neoplasm grade III to invasive cervical cancer
18. The use of polymerase chain reaction amplification for the detection of genital human papillomaviruses
19. Group-specific differentiation beween high- and low-risk human papillomavirus genotypes by general primer-mediated PCR and two cocktails of oligonucleotide probes
20. Analysis of cytomorphologically abnormal cervical scrapes for the presence of 27 mucosotropic human papillomavirus genotypes, using polymerase chain reaction
21. The polymerase chain reaction for human papillomavirus screening in diagnostic cytopathology of the cervix
22. Floating absolute risk: An alternative to relative risk in survival and case-control analysis avoiding an arbitrary reference group
23. Mortality associated with oral contraceptive use: 25 Year follow up of cohort of 46 000 women from Royal College of General Practitioners' oral contraception study
24. A review of problems of bias and confounding in epidemiologic studies of cervical neoplasia and oral contraceptive use
25. Persistence of type-specific human papillomavirus infection among cytologically normal women
26. Depot-medroxyprogesterone acetate, other injectable contraceptives, and cervical neoplasia
27. Prevalence of human papillomavirus in cervical cancer: A worldwide perspective
28. Epidemiologic evidence and human papillomavirus infection as a necessary cause of cervical cancer